US Drug Recall Register

FDA Drug Recalls

2,661 recalls, newest first

Class I · High risk Ongoing

Weiner Boner Honey

Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Pyramids Wholesale Inc. D-0449-2024
Class I · High risk Ongoing

Spanish Fly 22K capsules

Reason Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.

Pyramids Wholesale Inc. D-0448-2024
Class II · Moderate risk Ongoing

Infumorph

Reason The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.

Hikma Pharmaceuticals USA Inc. NDC 0641-6039-01 D-0392-2024
Class I · High risk Ongoing

Treprostinil Injection

Reason Presence of Particulate Matter.

Par Sterile Products LLC D-0429-2024
Class II · Moderate risk Ongoing

Febuxostat Tablets 80mg

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 16714-060-01 D-0369-2024
Class II · Moderate risk Ongoing

Febuxostat Tablets 40mg

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 16714-059-01 D-0368-2024
Class II · Moderate risk Ongoing

FentaNYL citrate

Reason Lack of Assurance of Sterility: Firm did not perform process validation.

SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0436-2024
Class II · Moderate risk Ongoing

Phenylephrine HCl

Reason Lack of Assurance of Sterility: Firm did not perform process validation.

SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0435-2024
Class II · Moderate risk Ongoing

hyalogic For Dry Eyes

Reason Lack of Assurance of Sterility

Optikem International, Inc. D-0384-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Red Eye Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-158-15 D-0383-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Pink Eye Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-013-15 D-0382-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Aging Eye Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-027-15 D-0381-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Floaters Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-098-15 D-0380-2024
Class II · Moderate risk Ongoing

TRP Eye strain Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-172-15 D-0379-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Dryness Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-178-15 D-0378-2024
Class II · Moderate risk Ongoing

TRP Eye Twitching Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-040-15 D-0377-2024
Class II · Moderate risk Ongoing

TRP Blur Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-002-11 D-0376-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Allergy Eyes Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-032-15 D-0375-2024
Class II · Moderate risk Ongoing

Nicardipine Hydrochloride Injection

Reason Failed Impurities/Degradation Specifications: Out of specification for organic impurities

Eugia US LLC NDC 55150-183-11 D-0391-2024
Class II · Moderate risk Ongoing

Nicardipine Hydrochloride Injection

Reason Failed Impurities/Degradation Specifications: Out of specification for organic impurities

Eugia US LLC NDC 55150-183-10 D-0390-2024
Class III · Low risk Ongoing

Clindamycin Phosphate Topical Solution USP

Reason Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Contract Pharmaceuticals Limited Canada NDC 71428-0003-60 D-0365-2024
Class III · Low risk Ongoing

Clindamycin Phosphate

Reason Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Contract Pharmaceuticals Limited Canada NDC 10135-0691-61 D-0364-2024
Class II · Moderate risk Ongoing

Lidocaine HCL 1%

Reason Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Denver Solutions, LLC DBA Leiters Health NDC 71449-090-42 D-0363-2024
Class II · Moderate risk Ongoing

Moxifloxacin 5mg/ml

Reason Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Denver Solutions, LLC DBA Leiters Health NDC 71449-097-42 D-0362-2024